Email not displaying properly? View email in your browser
Vertical-Talk Pharma   >  Chemotherapeutic Drug
>  Inflammatory Reaction
>  Antimalarial Agents
  May 2020   e-Newsletter Advertise | Editorial Calendar  
Catalent
Latest e-book
News
FDA approves Takeda's ALUNBRIG ® (brigatinib)...
Tavotek Announces a Research Agreement...
Press Releases
Zealand Pharma announces FDA...
Innovent Announces First Patient Dosed in A...
Events
01 - 03 Sep 2020
LogiPharma 2020
02 - 03 Sep 2020
3rd Annual Injectable Drug Delivery Conference
09 - 11 Sep 2020
MEDICAL FAIR ASIA 2020
Articles
>  Nano-based Drug Delivery System for Hacking Colon Cancer Cells
R Suresh kumar, Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research
Nano carriers can effectively increase the threshold capacity of the chemotherapeutic drug inside the cancer cells by involving in the target specific action and altering the multidrug resistance issue. Common tumor arising from the inner wall of the large intestine cells and concurring the same with lipid-based Nano carriers...
Techno Trends
> Trinity Researchers Discovered a New Breakthrough for Asthma Patients
> New AntiMalaria Agents to Block Malaria Transmission
Projects
> Audentes Therapeutics to Build US$109 million Gene Therapy...
> FUJIFILM Diosynth Biotechnologies Starts North Carolina Facility...
Research Insights
> Chromatin-enriched RNAs mark active and repressive cis-regulation...
> The Research and Development Process for Multiscale Models...
  Subscribe  |  e-Book Archives  | Advisory Board  
Follow Us Facebook Twitter linkedin
www.pharmafocusasia.com - Owned by Ochre Media Pvt. Ltd.